Cleared Abbreviated

K041687 - ABBOTT IMMUNOASSAY/CLINICAL CHEMISTRY S...

K041687 is an FDA 510(k) clearance for ABBOTT IMMUNOASSAY/CLINICAL CHEMISTRY S..., manufactured by Abbott Laboratories. The device is a Class 1 Chemistry device with product code JJX cleared through the Abbreviated 510(k) pathway after a 57-day FDA review.

K041687 · Abbott Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2004
Decision
57d
Days
Class 1
Risk

K041687 is an FDA 510(k) clearance for the ABBOTT IMMUNOASSAY/CLINICAL CHEMISTRY SINGLE ANALYTE QUALITY CONTROL MATERIAL.... Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on August 18, 2004 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K041687

510(k) Number K041687 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 22, 2004
Decision Date August 18, 2004
Days to Decision 57 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 88d · This submission: 57d
Pathway characteristics
Standards-based clearance path.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 397
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K041687.
MAS, DADE AND LIQUID ASSAYED DIABETES CONTROL
K042717 · Medical Analysis Systems, Inc. · Nov 2004
LIQUICHEK ELEVATED CRP CONTROL
K042837 · Bio-Rad · Nov 2004
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HBS CONTROLS
K042303 · Ortho-Clinical Diagnostics · Sep 2004
ABBOTT ARCHITECT STAT TROPONIN I LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL L, M AND H
K041194 · Medical Analysis Systems, Inc. · Aug 2004
CLINIQA LIQUID QC TDM CONTROLS LEVELS 1,2 & 3/CLINIQA LINICAL TDM CALIBRATION VERIFIERS LEVELS A-E FOR OLYMPUS AU SYSTEM
K041898 · Cliniqa Corporation · Aug 2004
WAKO LIPID CONTROL, LEVEL 1 AND LEVEL 2
K040918 · Wako Chemicals USA, Inc. · May 2004